Efficacy and Safety of ZSP1273 in Children 12-17 Years Old With Influenza A

Summary

This trial is conducted in China. This is a multi-center, randomized, double-blind, placebo-controlled clinical trial to assess the efficacy and safety of ZSP1273 in the treatment of Acute Uncomplicated influenza A in adolescents.

Timeline

Start

2025-11-08

Primary completion

2025-12-22

Completion

2025-12-31

Drugs

Indications